![Ken Yamazumi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Yamazumi
Direktor/Vorstandsmitglied bei
SanBio, Inc.
Profil
Ken Yamazumi is currently the Director & External Auditor at SanBio, Inc. He was previously the Chairman & President at Kirin Pharma Co. Ltd. from 2007 to 2008, and the Representative Director & Executive Vice President at Kyowa Kirin Co., Ltd. from 2011 to 2012.
Mr. Yamazumi received his undergraduate degree from the University of Tokyo in 1973.
Aktive Positionen von Ken Yamazumi
| Unternehmen | Position | Beginn |
|---|---|---|
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ken Yamazumi
| Unternehmen | Position | Ende |
|---|---|---|
| KYOWA KIRIN CO., LTD. | Direktor/Vorstandsmitglied | 22.03.2012 |
Kirin Pharma Co. Ltd.
 Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Vorsitzender | 06.10.2008 |
Ausbildung von Ken Yamazumi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Health Services |
Kyowa Kirin Co., Ltd.
 Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
